{"entity":{"type":"insider","cik":"0001492123","url":"/insider/0001492123","json_url":"/insider/0001492123.json","name":"Valenzano Ken","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":10,"first":"2011-05-25","last":"2015-07-15","span_basis":"filed_date"},"name_variants":[{"name":"Valenzano Ken","source":"filing","n_filings":10,"first_seen":"2011-05-25","last_seen":"2015-07-15"}],"transactions":[{"id":8603428,"accession":"0001209191-15-060935","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-060935","line_url":"/filing/0001209191-15-060935","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (SVP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (SVP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":27687.0,"shares_owned_after_display":"27,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-13","filed_date":"2015-07-15","scope":"insider","n_lines":3},{"id":8578031,"accession":"0001209191-15-056046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-056046","line_url":"/filing/0001209191-15-056046#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (SVP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (SVP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20500.0,"shares_display":"20,500","price_per_share":13.8543,"price_display":"13.85","price_state":"stated","total_value":284013.15,"total_display":"284,013.15","total_whole":"284,013","shares_owned_after":27687.0,"shares_owned_after_display":"27,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-22","filed_date":"2015-06-24","scope":"insider"},{"id":8093256,"accession":"0001209191-15-042027","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-042027","line_url":"/filing/0001209191-15-042027","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (SVP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (SVP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":10.846915384615384,"price_display":"10.85","price_state":"stated","total_value":141009.9,"total_display":"141,009.90","total_whole":"141,010","shares_owned_after":2687.0,"shares_owned_after_display":"2,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-11","filed_date":"2015-05-12","scope":"insider","n_lines":2},{"id":8294386,"accession":"0001209191-15-035041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-035041","line_url":"/filing/0001209191-15-035041#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (VP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (VP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":62500.0,"total_display":"62,500.00","total_whole":"62,500","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-15","filed_date":"2015-04-17","scope":"insider"},{"id":8691624,"accession":"0001209191-15-029055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-029055","line_url":"/filing/0001209191-15-029055#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (VP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (VP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13050.0,"shares_display":"13,050","price_per_share":11.5326,"price_display":"11.53","price_state":"stated","total_value":150500.43,"total_display":"150,500.43","total_whole":"150,500","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-24","scope":"insider"},{"id":8081948,"accession":"0001209191-15-029060","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-029060","line_url":"/filing/0001209191-15-029060","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (VP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (VP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7751.0,"shares_display":"7,751","price_per_share":11.771245839246548,"price_display":"11.77","price_state":"stated","total_value":91238.9265,"total_display":"91,238.93","total_whole":"91,239","shares_owned_after":51708.0,"shares_owned_after_display":"51,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-25","scope":"insider","n_lines":2},{"id":6297556,"accession":"0001209191-14-071260","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-071260","line_url":"/filing/0001209191-14-071260#line-4","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (VP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (VP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-25","scope":"insider"},{"id":6297555,"accession":"0001209191-14-071260","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-071260","line_url":"/filing/0001209191-14-071260","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (VP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (VP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":70000.0,"shares_owned_after_display":"70,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-25","scope":"insider","n_lines":3},{"id":6322373,"accession":"0001209191-14-054454","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-054454","line_url":"/filing/0001209191-14-054454#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (VP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (VP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12450.0,"shares_display":"12,450","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":74700.0,"total_display":"74,700.00","total_whole":"74,700","shares_owned_after":51708.0,"shares_owned_after_display":"51,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-25","filed_date":"2014-08-26","scope":"insider"},{"id":6322372,"accession":"0001209191-14-054454","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-054454","line_url":"/filing/0001209191-14-054454","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (VP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (VP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12450.0,"shares_display":"12,450","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":74700.0,"total_display":"74,700.00","total_whole":"74,700","shares_owned_after":59158.0,"shares_owned_after_display":"59,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-25","filed_date":"2014-08-26","scope":"insider","n_lines":2},{"id":7001110,"accession":"0001209191-14-053863","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-053863","line_url":"/filing/0001209191-14-053863#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (VP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (VP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":37800.0,"total_display":"37,800.00","total_whole":"37,800","shares_owned_after":51708.0,"shares_owned_after_display":"51,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-20","filed_date":"2014-08-21","scope":"insider"},{"id":7001109,"accession":"0001209191-14-053863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-053863","line_url":"/filing/0001209191-14-053863#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (VP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (VP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmacology & Biology","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":37800.0,"total_display":"37,800.00","total_whole":"37,800","shares_owned_after":58708.0,"shares_owned_after_display":"58,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-20","filed_date":"2014-08-21","scope":"insider"},{"id":9192904,"accession":"0001209191-11-030918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-030918","line_url":"/filing/0001209191-11-030918#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001492123","owner_name":"Valenzano Ken","owner_display_name":"Valenzano Ken","owner_url":"/insider/0001492123","role":"Officer (VP, Pharmacology & Biology)","role_mark":"O","role_mark_label":"Officer (VP, Pharmacology & Biology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmacology & Biology","security_title":"Common Stock, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":16875.0,"total_display":"16,875.00","total_whole":"16,875","shares_owned_after":1708.0,"shares_owned_after_display":"1,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-24","filed_date":"2011-05-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS INC","url":"/issuer/0001178879","role":"Officer (SVP, Pharmacology & Biology)","n_filings":10,"first_seen":"2011-05-25","last_seen":"2015-07-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001492123","retrieved_at":"2026-08-23T17:42:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}